Clinical Trial Update: Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating sorafenib in combination with transarterial chemoembolization for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED